WO2003094882A1 - Skin whitening external preparation - Google Patents
Skin whitening external preparation Download PDFInfo
- Publication number
- WO2003094882A1 WO2003094882A1 PCT/JP2003/005702 JP0305702W WO03094882A1 WO 2003094882 A1 WO2003094882 A1 WO 2003094882A1 JP 0305702 W JP0305702 W JP 0305702W WO 03094882 A1 WO03094882 A1 WO 03094882A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- tocopherol phosphate
- skin whitening
- phosphate
- ingredient
- lotion
- Prior art date
Links
- 230000002087 whitening effect Effects 0.000 title claims abstract description 64
- 238000002360 preparation method Methods 0.000 title claims abstract description 50
- 229910019142 PO4 Inorganic materials 0.000 claims abstract description 65
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims abstract description 63
- 239000010452 phosphate Substances 0.000 claims abstract description 63
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 48
- 229930003799 tocopherol Natural products 0.000 claims abstract description 46
- 239000011732 tocopherol Substances 0.000 claims abstract description 46
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims abstract description 46
- 235000010384 tocopherol Nutrition 0.000 claims abstract description 43
- 229960001295 tocopherol Drugs 0.000 claims abstract description 43
- 208000012641 Pigmentation disease Diseases 0.000 claims abstract description 34
- 239000002537 cosmetic Substances 0.000 claims abstract description 34
- 150000003839 salts Chemical class 0.000 claims abstract description 24
- 230000002265 prevention Effects 0.000 claims abstract description 14
- 239000004480 active ingredient Substances 0.000 claims abstract description 8
- 239000006210 lotion Substances 0.000 claims description 78
- 239000000499 gel Substances 0.000 claims description 44
- JUIUXBHZFNHITF-IEOSBIPESA-N [(2r)-2,5,7,8-tetramethyl-2-[(4r,8r)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl] dihydrogen phosphate Chemical group OP(=O)(O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C JUIUXBHZFNHITF-IEOSBIPESA-N 0.000 claims description 32
- 239000000839 emulsion Substances 0.000 claims description 20
- GZIFEOYASATJEH-VHFRWLAGSA-N δ-tocopherol group Chemical group C[C@@]1(OC2=C(C=C(C=C2CC1)O)C)CCC[C@@H](CCC[C@@H](CCCC(C)C)C)C GZIFEOYASATJEH-VHFRWLAGSA-N 0.000 claims description 18
- QUEDXNHFTDJVIY-DQCZWYHMSA-N γ-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-DQCZWYHMSA-N 0.000 claims description 15
- GZIFEOYASATJEH-UHFFFAOYSA-N D-delta tocopherol Natural products OC1=CC(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 GZIFEOYASATJEH-UHFFFAOYSA-N 0.000 claims description 12
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 7
- 235000010389 delta-tocopherol Nutrition 0.000 claims description 6
- 235000010382 gamma-tocopherol Nutrition 0.000 claims description 6
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 6
- 239000002478 γ-tocopherol Substances 0.000 claims description 6
- 239000002446 δ-tocopherol Substances 0.000 claims description 6
- 239000001257 hydrogen Substances 0.000 claims description 5
- 229910052739 hydrogen Inorganic materials 0.000 claims description 5
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 3
- 159000000000 sodium salts Chemical class 0.000 claims description 3
- 125000003810 γ-tocopherol group Chemical group 0.000 claims description 2
- 239000004615 ingredient Substances 0.000 description 104
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 57
- 239000011734 sodium Substances 0.000 description 51
- 229910052708 sodium Inorganic materials 0.000 description 51
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 49
- 235000021317 phosphate Nutrition 0.000 description 49
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 39
- 238000003756 stirring Methods 0.000 description 35
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 27
- MIJPAVRNWPDMOR-ZAFYKAAXSA-N L-ascorbic acid 2-phosphate Chemical compound OC[C@H](O)[C@H]1OC(=O)C(OP(O)(O)=O)=C1O MIJPAVRNWPDMOR-ZAFYKAAXSA-N 0.000 description 26
- 239000008213 purified water Substances 0.000 description 26
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 25
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 25
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 25
- 229960002216 methylparaben Drugs 0.000 description 25
- 230000019612 pigmentation Effects 0.000 description 25
- 239000000243 solution Substances 0.000 description 20
- 239000012456 homogeneous solution Substances 0.000 description 15
- 230000000694 effects Effects 0.000 description 10
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 9
- 229940073665 octyldodecyl myristate Drugs 0.000 description 9
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 7
- 230000000052 comparative effect Effects 0.000 description 7
- 239000011777 magnesium Substances 0.000 description 7
- 229910052749 magnesium Inorganic materials 0.000 description 7
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 6
- OBETXYAYXDNJHR-UHFFFAOYSA-N 2-Ethylhexanoic acid Chemical compound CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 6
- SHZIWNPUGXLXDT-UHFFFAOYSA-N caproic acid ethyl ester Natural products CCCCCC(=O)OCC SHZIWNPUGXLXDT-UHFFFAOYSA-N 0.000 description 6
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 6
- -1 α-tocopherol Chemical compound 0.000 description 6
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 5
- 239000007970 homogeneous dispersion Substances 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 239000008406 cosmetic ingredient Substances 0.000 description 4
- 230000003449 preventive effect Effects 0.000 description 4
- 229960000984 tocofersolan Drugs 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 239000012074 organic phase Substances 0.000 description 3
- 235000019149 tocopherols Nutrition 0.000 description 3
- QUEDXNHFTDJVIY-UHFFFAOYSA-N γ-tocopherol Chemical class OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-UHFFFAOYSA-N 0.000 description 3
- 241000208140 Acer Species 0.000 description 2
- 208000019300 CLIPPERS Diseases 0.000 description 2
- 241000700198 Cavia Species 0.000 description 2
- 241000700199 Cavia porcellus Species 0.000 description 2
- 235000001815 DL-alpha-tocopherol Nutrition 0.000 description 2
- 239000011627 DL-alpha-tocopherol Substances 0.000 description 2
- MLSJBGYKDYSOAE-DCWMUDTNSA-N L-Ascorbic acid-2-glucoside Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C1O MLSJBGYKDYSOAE-DCWMUDTNSA-N 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 206010039580 Scar Diseases 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 125000005210 alkyl ammonium group Chemical group 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 208000021930 chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids Diseases 0.000 description 2
- 239000007854 depigmenting agent Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000011888 foil Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 235000004835 α-tocopherol Nutrition 0.000 description 2
- 239000002076 α-tocopherol Substances 0.000 description 2
- WGVKWNUPNGFDFJ-DQCZWYHMSA-N β-tocopherol Chemical compound OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C WGVKWNUPNGFDFJ-DQCZWYHMSA-N 0.000 description 2
- 150000005208 1,4-dihydroxybenzenes Chemical class 0.000 description 1
- CSHZYWUPJWVTMQ-UHFFFAOYSA-N 4-n-Butylresorcinol Chemical compound CCCCC1=CC=C(O)C=C1O CSHZYWUPJWVTMQ-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 description 1
- ATJXMQHAMYVHRX-CPCISQLKSA-N Ellagic acid Natural products OC1=C(O)[C@H]2OC(=O)c3cc(O)c(O)c4OC(=O)C(=C1)[C@H]2c34 ATJXMQHAMYVHRX-CPCISQLKSA-N 0.000 description 1
- 229920002079 Ellagic acid Polymers 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- MSCCTZZBYHQMQJ-AZAGJHQNSA-N Tocopheryl nicotinate Chemical compound C([C@@](OC1=C(C)C=2C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC1=C(C)C=2OC(=O)C1=CC=CN=C1 MSCCTZZBYHQMQJ-AZAGJHQNSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- OEWBEINAQKIQLZ-CMRBMDBWSA-N [(2s)-2-[(2r)-3,4-bis(2-hexyldecanoyloxy)-5-oxo-2h-furan-2-yl]-2-(2-hexyldecanoyloxy)ethyl] 2-hexyldecanoate Chemical compound CCCCCCCCC(CCCCCC)C(=O)OC[C@H](OC(=O)C(CCCCCC)CCCCCCCC)[C@H]1OC(=O)C(OC(=O)C(CCCCCC)CCCCCCCC)=C1OC(=O)C(CCCCCC)CCCCCCCC OEWBEINAQKIQLZ-CMRBMDBWSA-N 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 150000004347 all-trans-retinol derivatives Chemical class 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 229940072107 ascorbate Drugs 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 229940067599 ascorbyl glucoside Drugs 0.000 description 1
- 229940066595 beta tocopherol Drugs 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 229940119217 chamomile extract Drugs 0.000 description 1
- 235000020221 chamomile extract Nutrition 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- VZWXIQHBIQLMPN-UHFFFAOYSA-N chromane Chemical group C1=CC=C2CCCOC2=C1 VZWXIQHBIQLMPN-UHFFFAOYSA-N 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- RCJVRSBWZCNNQT-UHFFFAOYSA-N dichloridooxygen Chemical compound ClOCl RCJVRSBWZCNNQT-UHFFFAOYSA-N 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 229960002852 ellagic acid Drugs 0.000 description 1
- 235000004132 ellagic acid Nutrition 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 229940114123 ferulate Drugs 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 229940106054 hexyl decanoate Drugs 0.000 description 1
- BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 description 1
- 150000002431 hydrogen Chemical group 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- NIQQIJXGUZVEBB-UHFFFAOYSA-N methanol;propan-2-one Chemical compound OC.CC(C)=O NIQQIJXGUZVEBB-UHFFFAOYSA-N 0.000 description 1
- FAARLWTXUUQFSN-UHFFFAOYSA-N methylellagic acid Natural products O1C(=O)C2=CC(O)=C(O)C3=C2C2=C1C(OC)=C(O)C=C2C(=O)O3 FAARLWTXUUQFSN-UHFFFAOYSA-N 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 1
- 230000000865 phosphorylative effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 239000002884 skin cream Substances 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 150000003611 tocopherol derivatives Chemical class 0.000 description 1
- 229950009883 tocopheryl nicotinate Drugs 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 150000003751 zinc Chemical class 0.000 description 1
- 235000007680 β-tocopherol Nutrition 0.000 description 1
- 239000011590 β-tocopherol Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/04—Preparations for care of the skin for chemically tanning the skin
Definitions
- the present invention relates to skin whitening external
- polyphenols are widely known to have
- Cosmetics often contain vitamin C or a derivative thereof
- Tocopherols knows as vitamin E (e.g., ⁇ -tocopherol,
- tocopherol derivatives are oil soluble to cause
- compositions that comprise tocopherol phosphate and/or a salt
- the invention relates to:
- active ingredient capable of prevention and/or removal of skin
- Ri, R 2 and R 3 are each hydrogen or a methyl group.
- ⁇ -tocopherol phosphate is dl- ⁇ -tocopherol phosphate .
- ⁇ -tocopherol phosphate is d- ⁇ -tocopherol phosphate
- ⁇ -tocopherol phosphate is d- ⁇ -tocopherol
- a cosmetic comprising the skin whitening external
- a skin whitening method comprising percutaneously
- the tocopherol phosphate is, for example, represented
- R x , R 2 and R 3 are each hydrogen or a methyl group.
- the tocopherol phosphate Preferably, and most usually, the tocopherol phosphate
- Rj . is a methyl group and R 2 and R 3 are both hydrogen.
- sodium salt is particularly preferable since
- the tocopherol phosphate of the formula (1) has an
- the tocopherol phosphate and/or the salt thereof can be
- the objective tocopherol phosphate can be any conventional method, e.g., JP-A-59 (1984 ) /44375 Specifically, the objective tocopherol phosphate can be any conventional method, e.g., JP-A-59 (1984 ) /44375 Specifically, the objective tocopherol phosphate can be
- the objective salt of tocopherol phosphate can be
- metallic oxide such as magnesium oxide, a metallic hydroxide
- skin whitening means that
- the skin whitening external preparations can prevent and/or
- the active ingredients the tocopherol phosphate and the
- pigmentation are used in amounts appropriately controlled
- skin whitening agent contains the tocopherol phosphate and/or
- the salt thereof in 0.1 to 10 % by mass.
- the skin whitening external preparations can be used as
- the cosmetics may be any kind of cosmetics usable in
- cosmetics include skin milks,
- creams shaving creams, cleansing foams, skin toners, lotions,
- the skin whitening external preparations may contain
- the skin whitening preparations can achieve particularly
- ingredients such as arbutin, ellagic acid, kojic acid,
- chamomile extract and Rucinol may by used in combination.
- the cosmetics are used for the purpose of cosmetic care.
- gel emulsion or liquid, such as gel emulsions, cosmetic
- compositions of the emulsions, cosmetic are included in the emulsions, cosmetically.
- liquids, etc. are not specifically limited and can be in accordance with commonly allied formulations.
- reaction was further conducted at room temperature for 3 hours .
- the precipitated salt was dissolved by addition of 100 ml of
- ingredients 1) to 4) was added to the ingredient 5) with
- ingredients 1) to 4) was added to the ingredient 5) with
- ingredients 1) to 4) was added to the ingredient 5) with
- ingredients 1) to 4) was added to the ingredient 5) with
- ingredients 1) to 4) was added to the ingredient 5) with
- ingredients 1) to 4) was added to the ingredient 5) with
- ingredients 1) to 3) was added to the ingredient 4) with
- ingredients 1) to 4) was added to the ingredient 5) with
- ingredients 1) to 4) was added to the ingredient 5) with
- ingredients 1) to 4) was added to the ingredient 5) with
- ingredients 1) to 4) was added to the ingredient 5) with
- ingredients 1) to 4) was added to the ingredient 5) with
- the ingredient 1) was added to the ingredient 2) with
- UVB ultraviolet beams
- the exposed skin was covered with an adhesive stretch bandage
- UVB ultraviolet beams
- Emulsion 2 A homogeneous solution consisting of the ingredients 1)
- the skin whitening external preparations contain the
- the external preparations have excellent skin appearance
- the cosmetics comprising the above skin whitening
- forms such as gels, emulsions and liquids, particularly
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Cosmetics (AREA)
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2004-7017942A KR20050003417A (en) | 2002-05-09 | 2003-05-07 | Skin Whitening External Preparation |
EP03721055A EP1501474A1 (en) | 2002-05-09 | 2003-05-07 | Skin whitening external preparation |
AU2003224458A AU2003224458A1 (en) | 2002-05-09 | 2003-05-07 | Skin whitening external preparation |
US10/513,371 US20050220733A1 (en) | 2002-05-09 | 2003-05-07 | Skin whitening external preparation |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JPNO.2002-134440 | 2002-05-09 | ||
JP2002134440 | 2002-05-09 | ||
US37975302P | 2002-05-14 | 2002-05-14 | |
US60/379,753 | 2002-05-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2003094882A1 true WO2003094882A1 (en) | 2003-11-20 |
Family
ID=33524422
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2003/005702 WO2003094882A1 (en) | 2002-05-09 | 2003-05-07 | Skin whitening external preparation |
Country Status (6)
Country | Link |
---|---|
US (1) | US20050220733A1 (en) |
EP (1) | EP1501474A1 (en) |
KR (1) | KR20050003417A (en) |
CN (1) | CN1652746A (en) |
AU (1) | AU2003224458A1 (en) |
WO (1) | WO2003094882A1 (en) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004060341A2 (en) * | 2002-12-19 | 2004-07-22 | Access Business Group International Llc | Increasing skin cell renewal with water-soluble vitamin e |
WO2005094770A1 (en) * | 2004-03-30 | 2005-10-13 | Unilever Plc | Skin lightening compositions comprising vitamines and flavonoids |
WO2007109248A2 (en) * | 2006-03-20 | 2007-09-27 | Larry Schlesinger | Treatment or prevention of scarring, capsular contractures and/or hyperpigmentation using leukotriene receptor antagonist and vitamin e |
WO2008001921A2 (en) * | 2006-06-27 | 2008-01-03 | Showa Denko K.K. | Dermatological anti-wrinkle agent |
GB2486951A (en) * | 2010-12-30 | 2012-07-04 | Lvmh Rech | Cosmetic composition comprising a tocopherol phosphate and process for the preparation thereof |
EP2534950A1 (en) * | 2011-06-16 | 2012-12-19 | Dashmir Ismaili | Compound for use on plants, in particular plant protection agent, plant regeneration agent and/or plant growth agent and method for producing same |
WO2015092227A1 (en) | 2013-12-20 | 2015-06-25 | Lvmh Recherche | Use of tocopherol phosphate as a hydrating agent |
WO2016031634A1 (en) * | 2014-08-29 | 2016-03-03 | Showa Denko K. K. | Skin color-improving agent and composition for improving skin color |
EP3299376A4 (en) * | 2015-05-20 | 2018-12-19 | Showa Denko K.K. | Tocopherol phosphate ester salt and method for producing same, and external skin preparation |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101238703B1 (en) * | 2004-08-03 | 2013-03-04 | 바이탈 헬스 사이언시즈 피티와이 리미티드 | Carrier for enteral administration |
US20090239827A1 (en) * | 2005-03-03 | 2009-09-24 | Esra Ogru | Compounds having lipid lowering properties |
ES2557475T3 (en) | 2005-06-17 | 2016-01-26 | Vital Health Sciences Pty Ltd. | A carrier comprising one or more di- and / or monophosphate derivatives of electron transfer agents |
US8344024B2 (en) * | 2007-07-31 | 2013-01-01 | Elc Management Llc | Anhydrous cosmetic compositions containing resveratrol derivatives |
US9295621B2 (en) * | 2007-07-31 | 2016-03-29 | Elc Management Llc | Emulsion cosmetic compositions containing resveratrol derivatives and silicone surfactant |
US20090035236A1 (en) * | 2007-07-31 | 2009-02-05 | Maes Daniel H | Emulsion Cosmetic Compositions Containing Resveratrol Derivatives And An Oil Phase Structuring Agent |
US8080583B2 (en) * | 2007-07-31 | 2011-12-20 | Elc Management Llc | Emulsion cosmetic compositions containing resveratrol derivatives and linear or branched silicone |
CN101854903B (en) * | 2007-09-08 | 2012-07-04 | Elc管理有限责任公司 | Resveratrol ferulate compounds, compositions containing the compounds, and methods of using the same |
WO2011094814A1 (en) * | 2010-02-05 | 2011-08-11 | Phosphagenics Limited | Carrier comprising non-neutralised tocopheryl phosphate |
ES2829386T3 (en) | 2010-03-30 | 2021-05-31 | Phosphagenics Ltd | Transdermal administration patch |
EP2685992A4 (en) | 2011-03-15 | 2014-09-10 | Phosphagenics Ltd | Amino-quinolines as kinase inhibitors |
US10973761B2 (en) | 2015-12-09 | 2021-04-13 | Phosphagenics Limited | Pharmaceutical formulation |
CN110662733A (en) | 2016-12-21 | 2020-01-07 | 埃维科生物技术有限公司 | Method of producing a composite material |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991011189A1 (en) * | 1990-01-31 | 1991-08-08 | Lvmh Recherche | USE OF AN α-TOCOPHEROL PHOSPHATE OR A DERIVATIVE THEREOF FOR PREPARING COSMETIC, DERMATOLOGICAL OR PHARMACEUTICAL COMPOSITIONS, AND COMPOSITIONS THEREBY OBTAINED |
EP0798305A1 (en) * | 1995-10-17 | 1997-10-01 | Showa Denko Kabushiki Kaisha | High-purity tocopherol phosphates, process for the preparation thereof, method for analysis thereof, and cosmetics |
JPH09309813A (en) * | 1996-05-22 | 1997-12-02 | Nonogawa Shoji Kk | Preparation for external use for skin |
JPH11199424A (en) * | 1997-12-26 | 1999-07-27 | Nonogawa Shoji Kk | Skin preparation for external use |
JPH11199465A (en) * | 1998-01-07 | 1999-07-27 | Nonogawa Shoji Kk | Skin preparation for external use |
US5932612A (en) * | 1997-08-05 | 1999-08-03 | Medicis Pharmaceutical Corp. | Compositions and systems for the treatment of hyperpigmentation |
FR2777179A1 (en) * | 1998-04-09 | 1999-10-15 | Lvmh Rech | Cosmetic and dermatological composition with non-greasy feel and useful as carrier |
JP2001081022A (en) * | 1999-09-10 | 2001-03-27 | Kanebo Ltd | Skin cosmetic and black rings-improving agent |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2763336B1 (en) * | 1997-05-14 | 1999-08-06 | Lvmh Rech | ESTERS OF TOCOPHEROL AND THEIR USES IN COSMETICS AND PHARMACY |
-
2003
- 2003-05-07 AU AU2003224458A patent/AU2003224458A1/en not_active Abandoned
- 2003-05-07 WO PCT/JP2003/005702 patent/WO2003094882A1/en active Application Filing
- 2003-05-07 US US10/513,371 patent/US20050220733A1/en not_active Abandoned
- 2003-05-07 EP EP03721055A patent/EP1501474A1/en not_active Withdrawn
- 2003-05-07 KR KR10-2004-7017942A patent/KR20050003417A/en not_active Application Discontinuation
- 2003-05-07 CN CNA038104598A patent/CN1652746A/en active Pending
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991011189A1 (en) * | 1990-01-31 | 1991-08-08 | Lvmh Recherche | USE OF AN α-TOCOPHEROL PHOSPHATE OR A DERIVATIVE THEREOF FOR PREPARING COSMETIC, DERMATOLOGICAL OR PHARMACEUTICAL COMPOSITIONS, AND COMPOSITIONS THEREBY OBTAINED |
EP0798305A1 (en) * | 1995-10-17 | 1997-10-01 | Showa Denko Kabushiki Kaisha | High-purity tocopherol phosphates, process for the preparation thereof, method for analysis thereof, and cosmetics |
JPH09309813A (en) * | 1996-05-22 | 1997-12-02 | Nonogawa Shoji Kk | Preparation for external use for skin |
US5932612A (en) * | 1997-08-05 | 1999-08-03 | Medicis Pharmaceutical Corp. | Compositions and systems for the treatment of hyperpigmentation |
JPH11199424A (en) * | 1997-12-26 | 1999-07-27 | Nonogawa Shoji Kk | Skin preparation for external use |
JPH11199465A (en) * | 1998-01-07 | 1999-07-27 | Nonogawa Shoji Kk | Skin preparation for external use |
FR2777179A1 (en) * | 1998-04-09 | 1999-10-15 | Lvmh Rech | Cosmetic and dermatological composition with non-greasy feel and useful as carrier |
JP2001081022A (en) * | 1999-09-10 | 2001-03-27 | Kanebo Ltd | Skin cosmetic and black rings-improving agent |
Non-Patent Citations (4)
Title |
---|
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; AOKI, YUZURU ET AL: "Skin cosmetics containing vitamin E derivatives and Citrus junos extracts", XP002250037, retrieved from STN Database accession no. 134:256613 CA * |
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; YASHIRO, YOICHI ET AL: "Nonionic surfactant-free skin preparations containing.alpha.-tocopherol phosphates", XP002250263, retrieved from STN Database accession no. 128:66322 CA * |
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; YASHIRO, YOICHI ET AL: "Skin cosmetics containing tocopheryl phosphate", XP002250264, retrieved from STN Database accession no. 131:134405 CA * |
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; YASHIRO, YOICHI ET AL: "Skin preparations containing tocopheryl phosphates and polyhydric alcohols and/or acids", XP002250265, retrieved from STN Database accession no. 131:134403 CA * |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004060341A2 (en) * | 2002-12-19 | 2004-07-22 | Access Business Group International Llc | Increasing skin cell renewal with water-soluble vitamin e |
WO2004060341A3 (en) * | 2002-12-19 | 2005-03-03 | Access Business Group Int Llc | Increasing skin cell renewal with water-soluble vitamin e |
WO2005094770A1 (en) * | 2004-03-30 | 2005-10-13 | Unilever Plc | Skin lightening compositions comprising vitamines and flavonoids |
WO2007109248A3 (en) * | 2006-03-20 | 2008-03-20 | Larry Schlesinger | Treatment or prevention of scarring, capsular contractures and/or hyperpigmentation using leukotriene receptor antagonist and vitamin e |
WO2007109248A2 (en) * | 2006-03-20 | 2007-09-27 | Larry Schlesinger | Treatment or prevention of scarring, capsular contractures and/or hyperpigmentation using leukotriene receptor antagonist and vitamin e |
WO2008001921A2 (en) * | 2006-06-27 | 2008-01-03 | Showa Denko K.K. | Dermatological anti-wrinkle agent |
WO2008001921A3 (en) * | 2006-06-27 | 2008-03-20 | Showa Denko Kk | Dermatological anti-wrinkle agent |
GB2486951A (en) * | 2010-12-30 | 2012-07-04 | Lvmh Rech | Cosmetic composition comprising a tocopherol phosphate and process for the preparation thereof |
DE102011057030A1 (en) | 2010-12-30 | 2012-07-05 | Lvmh Recherche | Composition containing a tocopherol phosphate, and manufacturing method |
KR20120078600A (en) | 2010-12-30 | 2012-07-10 | 엘브이엠에이취 러쉐르쉐 | Composition comprising a tocopherol phosphate and preparation process |
GB2486951B (en) * | 2010-12-30 | 2013-10-23 | Lvmh Rech | Composition comprising a tocopherol phosphate and preparation process |
EP2534950A1 (en) * | 2011-06-16 | 2012-12-19 | Dashmir Ismaili | Compound for use on plants, in particular plant protection agent, plant regeneration agent and/or plant growth agent and method for producing same |
WO2015092227A1 (en) | 2013-12-20 | 2015-06-25 | Lvmh Recherche | Use of tocopherol phosphate as a hydrating agent |
WO2016031634A1 (en) * | 2014-08-29 | 2016-03-03 | Showa Denko K. K. | Skin color-improving agent and composition for improving skin color |
EP3299376A4 (en) * | 2015-05-20 | 2018-12-19 | Showa Denko K.K. | Tocopherol phosphate ester salt and method for producing same, and external skin preparation |
Also Published As
Publication number | Publication date |
---|---|
CN1652746A (en) | 2005-08-10 |
US20050220733A1 (en) | 2005-10-06 |
AU2003224458A1 (en) | 2003-11-11 |
EP1501474A1 (en) | 2005-02-02 |
KR20050003417A (en) | 2005-01-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20050220733A1 (en) | Skin whitening external preparation | |
EP1339413B1 (en) | Compositions comprising complexes of phosphate derivatives of tocopherol | |
JP2731705B2 (en) | Cosmetic composition and dermatological pharmaceutical composition | |
JP2764510B2 (en) | Whitening cosmetics | |
JP2003306419A (en) | Cosmetic | |
JP2711782B2 (en) | Whitening cosmetics | |
JP2001010926A (en) | Bleaching agent | |
JP2004026817A (en) | Skin care preparation for bleaching | |
JPH06321754A (en) | Skin beautifying agent | |
JP2003238333A (en) | Skin preparation for external use | |
JPH06172150A (en) | Skin cosmetic | |
JP2002234828A (en) | Skin whitening cosmetic preparation | |
JP2003321463A (en) | Skin care preparation | |
JP3819369B2 (en) | Whitening cosmetic | |
JPH0692833A (en) | Skin external agent | |
EP1996514B1 (en) | Removal of skin changes | |
EP1480609B1 (en) | Whitening cosmetic composition | |
JPH06312920A (en) | Skin-beautifying agent and skin cosmetic containing the agent | |
IL132854A (en) | Cosmetic composition and a method for reducing the ageing process of skin | |
JPH10194919A (en) | Skin lotion | |
KR20040057413A (en) | Cosmetic Product containing Ascorbic Acid-2-Glucoside | |
JP2003238386A (en) | Bleaching cosmetic | |
JPH08333232A (en) | Whitening agent | |
KR100591630B1 (en) | Whitening cosmetic composition | |
JP2001233757A (en) | Bleaching cosmetic |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 10513371 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003721055 Country of ref document: EP Ref document number: 1020047017942 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 20038104598 Country of ref document: CN |
|
WWP | Wipo information: published in national office |
Ref document number: 1020047017942 Country of ref document: KR |
|
WWP | Wipo information: published in national office |
Ref document number: 2003721055 Country of ref document: EP |